Clinical Characteristics of Seven Patients with Lanthanum Phosphate Deposition in the Stomach-Reference-Cited by-同舟云学术

Clinical Characteristics of Seven Patients with Lanthanum Phosphate Deposition in the Stomach

Published:2017 Issue:16 Volume:56 Page:2089-2095
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Murakami Naoko¹,Yoshioka Masao¹,Iwamuro Masaya²³,Nasu Junichirou¹,Nose Soichiro⁴,Shiode Junji¹,Okada Hiroyuki²,Yamamoto Kazuhide¹

Affiliation:

1. Department of Internal Medicine, Okayama Saiseikai General Hospital, Japan

2. Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan

3. Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan

4. Department of Anatomic Pathology, Okayama Saiseikai General Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/16/56_8720-16/_pdf

Reference23 articles.

1. 1. Delmez JA, Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 19: 303-317, 1992.

2. 2. Shigematsu T; Lanthanum Carbonate Research Group. One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis. Ther Apher Dial 14: 12-19, 2010.

3. 3. Tsuchida K, Nagai K, Yokota N, Minakuchi J, Kawashima S. Impact of lanthanum carbonate on prognosis of chronic hemodialysis patients: a retrospective cohort study (Kawashima Study). Ther Apher Dial 20: 142-148, 2016.

4. 4. Cernaro V, Santoro D, Lacquaniti A, et al. Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide. Int J Nephrol Renovasc Dis 9: 11-19, 2016.

5. 5. Giotta N, Marino AM. Pharmacoeconomic analysis: analysis of cost-effectiveness of lanthanum-carbonate (Lc) in uncontrolled hyperphosphatemia in dialysis. Value Health 18: A511, 2015.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Method for Detecting Lanthanum Phosphate Deposition in the Gastroduodenal Mucosa Using Fluorescence Microscopy;Cureus;2022-10-26

2. Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago;Clinical Case Reports;2021-11

3. New Kids on the Block;Archives of Pathology & Laboratory Medicine;2021-02-11

4. Investigation of the clinical significance and pathological features of lanthanum deposition in the gastric mucosa;BMC Gastroenterology;2020-11-23

5. Quantitative Visualization of Lanthanum Accumulation in Lanthanum Carbonate-Administered Human Stomach Tissues Using Mass Spectrometry Imaging;Mass Spectrometry;2020-07-13